Skip to main content

£50m for tackling disparities in maternal healthcare

Funding from the National Institute for Health and Care Research (NIHR) has established the NIHR Inequalities Challenge: Maternity Disparities Consortium which will unite higher education, NHS, community and voluntary organisations to close the most critical gaps in maternal care, under the leadership of the University of Birmingham and Newcastle University.

The NIHR has committed £50 million over five years to drive forward the vital research led by clinicians, researchers, and communities across the consortium marking the most significant step forward in maternal health research in a generation.

The launch comes at a pivotal moment for maternity care in the UK, with national attention increasingly focused on improving safety, equity and women’s experiences of care.

The Government’s renewed Women’s Health Strategy highlights the need to improve care before and between pregnancies for underserved communities, against this backdrop, the consortium will generate the evidence, interventions and research capacity needed to help translate national ambition into practical, equitable improvements for women, babies and families.

University of Birmingham is leading on improving maternity care pathways across the antenatal, intrapartum and postnatal periods, ensuring that every woman receives the right care, at the right time, throughout her pregnancy journey.

Professor Joht Singh Chandan, Consortium Co-lead for Research, University of Birmingham said: “National attention on maternity safety and equity has never been greater, but ambition must now be matched by evidence and implementation. Through this consortium, we will work across the UK to understand what works, for whom and in what contexts, and to ensure that research leads to practical changes in care for the women, babies and families who need them most.”

Professor Judith Rankin OBE, Consortium Co-lead for Research and Capacity Development, Newcastle University said: “This funding represents a critical opportunity to make the step change we need to improve outcomes for women and their babies. Alongside the research, the Consortium will be investing in tomorrow’s research leaders today to ensure we have the capacity to deliver on improving pregnancy outcomes, access to, and experience of, care.”

Maternal health inequalities remain one of the most pressing challenges facing the NHS. In the UK, Black women continue to face a substantially higher risk of dying during or after pregnancy than white women, and women and families living in the most deprived communities continue to experience poorer outcomes. These inequalities are not inevitable.

Dr Vicky Hodgetts Morton, Associate Professor in Obstetrics at the University of Birmingham, Consultant Obstetrician and Co-Lead of the consortium’s Pregnancy, birth and early postnatal mental health theme said: “Too many women and families continue to experience avoidable disparities in maternity care and outcomes. This Consortium brings together researchers, clinicians, women, families and communities from across the UK with a shared commitment to tackling these inequalities.

“Working alongside colleagues at the University of Birmingham, including Professor Laura Jones, Professor Katie Morris, Professor Amy Grove, Dr Sarah Hillman and Dr Michelle Fisher, and partners across the Consortium, we are combining scientific expertise, lived experience and strong partnerships to better understand why these disparities occur and, more importantly, develop solutions that make a real difference.”

Dr Michelle Fisher, Senior Research Fellow in Applied Health at the University of Birmingham, and Emerging Co-Lead of the Racism, Discrimination and Intersectionality workstream said: “This research consortium is an important advancement in enabling researchers, service users, charities, communities, clinicians, and leaders to tackle racism and discrimination in the maternity care system across the UK.”

The NIHR Maternity Disparities Consortium will bring together clinicians, researchers, women, families and communities across the UK to develop practical, evidence-based solutions that can improve care, reduce avoidable harm and support better outcomes for mothers, babies and families.

The NIHR Maternity Disparities Consortium is a first of a series of NIHR Inequality challenge focused fundings calls secured by the University of Birmingham which includes the NIHR Cardiovascular Inequalities Challenge.

Key areas of research

Before and between pregnancies (preconception and interpregnancy care)

The consortium will examine how women and families can be better supported before pregnancy and between pregnancies. This includes improving access to advice and care that can help people prepare for pregnancy, manage existing health conditions and reduce risks before they build up.

Pregnancy, birth and early recovery after birth

Research will focus on improving care during pregnancy, birth and the early weeks after birth. This will include work on major causes of poor maternal health, such as high blood pressure, diabetes in pregnancy, obesity, perinatal mental health and complications during recovery after birth.

Care for babies and families after birth

The consortium will develop and test better ways to support babies and families who are at higher risk of poor outcomes. This includes improving follow up care after birth, strengthening links between hospital and community services, and supporting families as they move from maternity and neonatal care into longer term child and family support.

Access, communication and experience of care

The programme will look at how services can be easier to access, easier to understand and more responsive to women and families. This includes improving communication, language support, shared decision making and the overall experience of care, particularly for those who are least well served by current systems.

Tackling racism, discrimination and unfairness

The consortium will ensure that research directly addresses racism, discrimination and other forms of unfairness that affect maternity care and outcomes. This will be built into how interventions are designed, delivered and evaluated.

Working with communities

Women, families and community organisations will help shape the research from the beginning. The consortium will work with peer researchers, charities and community partners to make sure the work reflects real experiences and is useful to the people most affected by maternity inequalities.

Using data and evidence to drive change

The programme will use data, digital tools, health economics and real-world evaluation to understand what works, for whom and in what circumstances. This will help identify practical changes that can be delivered fairly and scaled across different parts of the UK.

Birmingham-led team to tackle national health inequalities in heart disease

BHP founder-member the University of Birmingham is leading one of nine consortia that have been selected to take part in the NIHR Cardiovascular Inequalities Challenge. Developed in partnership with the British Heart Foundation, this £50 million project aims to tackle the huge inequalities that persist across under-served communities in the UK.

The research programme will focus on strengthening the detection and management of high blood pressure and cholesterol – two driving factors for diseases of the heart and circulation – and will be co-created with communities at-risk.

Heart attacks, strokes and other conditions such as vascular dementia are preventable with blood pressure and cholesterol-lowering treatment, yet most people are not diagnosed or treated effectively and continue to suffer these catastrophic events.

Leveraging both existing infrastructure and new technologies, the Challenge aims to address one of the UK’s biggest killers for all people, regardless of age, gender, ethnicity, social status, disability or culture.

Professor Dipak Kotecha, lead for the team, Professor of Cardiology at the University of Birmingham and researcher at the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, said: “Our part of this national collaboration includes a dynamic team of community representatives, public health and primary care clinicians, cardiovascular researchers, local and national government agencies, as well as industry partners and technology companies working together to effect sustainable change and pivot the NHS towards better prevention.”

The University of Birmingham-led consortium includes core partners such as fellow BHP members Aston University, as well as Citizens UK (the UK’s biggest and most diverse people-powered alliances), the London School of Economics and Political Science, and Birmingham City Council. As part of the project, this team will work with the eight other consortia across the UK to bring together a wealth of experience to address health inequality.

Professor Shivani Sharma, Deputy Pro Vice-Chancellor Research and Enterprise at Aston University, said: “At Aston, we’re deeply committed to inclusive and participatory research, creating spaces where people can shape both the questions and solutions.

“Through this consortium, we’re proud to bring tried-and-tested approaches that open the door for more people – especially those often ignored in research – to influence how we tackle cardiovascular health gaps. This isn’t about ticking a box. It’s about building engagement that feels accessible, relevant, and genuinely meaningful to communities.”

Dr Saidul Haque Saeed, Lead Organiser, West Midlands at Citizens UK, said: “Our mission at Citizens UK is to bring together everyday people and local organisations to build a better, fairer society. Together, we’re making change on the issues that matter, and we are excited to be a part of this vital project to address inequalities in cardiovascular health and help everyone have access to NHS care.”

Professor Elias Mossialos, Cheng Yu Tung Chair in Global Health and Director of LSE Health at the London School of Economics and Political Science, said: ‘We are delighted to contribute to this important consortium. Addressing inequalities in population health requires deep understanding of the social and economic conditions that shape how innovations work in practice.

“Our role will be to provide economic and policy analysis to evaluate the health, social, and economic impact of initiatives and generate evidence that supports sustainable and equitable health systems. This is an important opportunity to bring interdisciplinary expertise together in the service of fairer health outcomes.”

Becky Pollard, Assistant Director of Public Health at Birmingham City Council, said: “Tackling cardiovascular disease is a key priority for us and requires an approach across the city and nation that brings together councils, the NHS, community and voluntary sectors and wider society.”

“In addition to national and collaborative research projects, the NIHR Cardiovascular Inequalities Challenge will support and develop capacity across all stakeholders.

Professor Clare Taylor, Professor of General Practice at the University of Birmingham, said: “Capacity building is essential to realise our ambition to effect disruptive and sustainable change in cardiovascular inequality.”

Working together, the consortium aims to make a distinct difference in the lives of people across the UK who have less access to either existing or new and often life-saving treatments for heart disease. The consortium’s research projects aim to start later this year. The work will synergise with a range of other programmes led by the University of Birmingham and our partners that are already opening up the benefit of clinical research to broader populations. This includes the DaRe2THINK national primary care trial platform, the Cities@Heart Innovative Health Initiative, the West Midlands Secure Data Environment and the Living Lab for HealthTech.

Learn more about BHP’s health inequalities research theme

West Midlands Living Lab: connecting healthcare through technology

A new initiative will see researchers work with digital technology leaders and industry to meaningfully impact healthcare services and improve patient outcomes in the Midlands.

The West Midlands Living Lab will explore the use of digital technology to improve patient communication, enable community care, avoid unnecessary hospital admissions, and support a more prevention-based health service.

Working with worldwide technology giant Cisco, BHP founder-member the University of Birmingham will lead the latest of the Lister Alliance Living Labs in the country’s richly diverse second city. With approximately 6.2 million people, and more than 100 languages spoken, the diverse West Midlands population truly reflects the global community. Research conducted in the region will be widely applicable, meaning it provides the ideal test bed.

University Hospitals Birmingham’s Professor Simon Ball, who is also Senior Responsible Officer for the West Midlands Secure Data Environment and co-lead for the living lab said: “The West Midlands is the perfect place to do this innovative work, with our leading researchers bringing together key stakeholders to connect state-of-the-art NHS facilities and uniquely diverse local communities. Working with an industry partner with the capability and reach of Cisco working alongside us is a testament to the scale of our ambition and drive to improve health outcomes using innovative technology and analytics.”

Professor Neil Hanley, Pro Vice Chancellor and Head of College of Medicine and Health, said: “We’re delighted that the University of Birmingham, led by Professor Kotecha, is at the forefront of this collaboration. It was great to attend the recent launch event and inspiring to feel the cross-sector work- the genuine triple helix of universities, public sector and industry – all focussed on stopping readmission to hospital and, in particular, addressing the health inequalities associated with this. Aligning all this with skills, innovation, entrepreneurship and commercialisation really excites me. And of course, with the make-up of Birmingham and the West Midlands being the demographic of the world, lessons learned and experiences gained will be rapidly translatable across the UK and internationally.”

The West Midlands Living Lab, funded by Cisco’s Country Digital Acceleration programme, will take advantage of considerable and unique health data resources, including the West Midlands Secure Data Environment which is connecting health systems across the region, and DaRe2THINK, which provides a national digital clinical trial platform for NHS Primary Care.

Pilot studies are planned to run through community hubs, NHS Primary Care and hospital trusts, looking at how best to break down siloes between existing services and orchestrate better, connected health and social care. Partnerships with community organisations will help address the needs of diverse neighbourhoods and be a blueprint for global benefit.

Professor Dipak Kotecha, School of Medical Sciences, University of Birmingham, said: “Our new living lab focused on health technology will allow us to bring together health data and industry partners to innovate towards better healthcare for all. This includes exploring technologies for remote monitoring, developing AI tools for prediction, improving how people get discharged from hospital, and integrating health data to keep people informed and well in their own homes.

“For example, our previous research, now adopted into the NHS 10-year plan, has shown that wearable devices for health monitoring can provide information similar to that recorded at hospital visits. These early indications show promise for a less hospital-centric and more personalised approach to care, delivered in the community by using new healthtech.”

Declan Hadley, Healthcare Lead, Cisco UKI, said: “We are looking forward to harnessing the creativity, experience and collective capabilities in the West Midlands to improve routine NHS care through technology but also need to be mindful that we don’t exacerbate existing heath inequalities. Living labs are just as much about finding out what does work as what doesn’t, and we plan to achieve this through co-production with local community leaders.”

International initiative to tackle heart health inequalities in cities to be led from Birmingham

Researchers from BHP founder the University of Birmingham will collaborate with international partners on an ambitious project aiming to help reduce the burden of cardiovascular disease in urban environments, as well as reducing the health inequality gap.

Cardiovascular disease is the leading cause of death globally, accounting for over 20 million deaths per year and costing the EU an estimated €282bn annually. To tackle this, the European Union Innovative Health Initiative has funded the new Cities@Heart consortium which will design, pilot and evaluate a series of city-level strategies to improve cardiovascular health for all.

Addressing cardiovascular disease in urban environments is challenging due to factors like poor access to healthcare and healthy food, exposure to pollution, and lack of safe spaces for physical activity. Urban infrastructure, food systems, and socio-economic disparities also contribute to adverse cardiometabolic outcomes.

While there are many interventions for cardiovascular disease, a lack of effective implementation means these often fail to reach individuals who would benefit most. This is particularly evident in underserved city populations such as those experiencing poverty, and in certain ethnic groups, disabled people, and women.

Addressing these complex issues requires a whole-city, integrated approach that changes health policy through co-production of suitable interventions with communities and community leaders.

The Cities@Heart project, starting in January 2026 and coordinated by the University of Birmingham, the University Medical Center Utrecht (Netherlands) and Novartis (Switzerland), will combine medical, technical, social and policy innovations to achieve a transformation in outcomes for communities experiencing health inequality.

Led by Professor Dipak Kotecha, the project will utilise existing infrastructure from seven city councils across Europe, embedding new health innovations and technologies from industry partners to tackle the challenge of urban cardiovascular disease on a significant scale.

The strategies will target obesity, hypertension, dyslipidaemia and diabetes, key drives of common and high-cost cardiovascular disease, such as heart attacks, stroke, heart failure, atrial fibrillation and vascular dementia. These disproportionately impact underserved and disadvantaged communities in urban areas.

Professor Dipak Kotecha, Professor of Cardiology at the University of Birmingham, researcher at the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, through which this project will be delivered, Honorary Professor at the University Medical Center Utrecht and Global Director of Cities@Heart said: “Huge strides have been made to better manage disease of the heart and circulation, but they still remain the world’s biggest killers. We will jointly develop approaches with affected citizens, community leaders, city councils, clinicians, health policy leaders and industry partners to achieve long-term change.”

Collaboration across Europe

The project consortium involves 34 international partners, including the World Health Organization (WHO) European Healthy Cities Network, World Heart Federation, European Heart Network, European Society of Cardiology, European Public Health Association and multiple European universities.

Birmingham joins another six cities committed to city-wide improvement that will test and implement strategies that can be scaled across the WHO’s network of more than 1,800 cities: Belfast (Northern Ireland), Cork (Republic of Ireland), Łódź (Poland), Izmir (Turkey), Udine (Italy) and Utrecht (Netherlands).

The vision of the consortium is that evidence-based prevention, early detection, and management of cardiovascular disease is universally accessible in urban areas, supported by new health technology developments. The Cities@Heart project aims to reduce the economic burden of cardiovascular disease on society and improve quality-of-life and life expectancy for millions.

Lifesaving programme to prevent post-birth bleeding wins Times Higher Education STEM Award

A cost-effective intervention for postpartum haemorrhage, which has reduced maternal deaths worldwide by 60%, has won a major award in UK Higher Education.

The E-MOTIVE programme led by BHP founder-member the University of Birmingham and the World Health Organisation (WHO), with partners around the world, has been awarded Times Higher Education’s 2025 STEM award for best research in science, technology, engineering or mathematics.

Members of the E-MOTIVE team collect their award

The award was given to the low-cost set of interventions, which are being used to reduce deaths from childbirth-related bleeding – the leading cause of maternal mortality worldwide. It affects an estimated 24 million women each year and results in around 70,000 deaths – mostly in low and middle-income countries – equivalent to one death every seven minutes.

Professor Adam Devall from the University of Birmingham and an author of the study said: “We are delighted that E-MOTIVE has received recognition from the Times Higher Education awards, demonstrating the high calibre of research undertaken at the University of Birmingham.

“Childbirth-related bleeding is a major risk to life for women around the world, affecting an estimated 24 million women each year. E-MOTIVE is a powerful toolkit that is already being employed globally to dramatically reduce the numbers of women dying from excessive bleeding during childbirth.

“Continued international collaboration could see EMOTIVE prevent up to 20,000 maternal deaths a year, marking a revolution in maternal care.”

Following a landmark study published in the New England Journal of Medicine, the WHO has convened a group to draft its first official guidelines on bundled PPH care. It stated that bundled treatments could be provided for less than $1 per package – making them cheap enough to scale in low-income countries.

Four countries have now incorporated E-MOTIVE into their national clinical guidelines, with WHO updating its road map for addressing PPH. The Gates Foundation, which funded the trial, has pledged to invest a further $500 million (£375 million) into the treatments and further research as a result of its success.

Professor Arri Coomarasamy, Honorary Professor at the University of Birmingham who led the E-MOTIVE trial said: “E-MOTIVE has the power to radically improve women’s chances of surviving childbirth globally, helping them get the treatment they need when they need it.

“Time is of the essence when responding to postpartum bleeding, so interventions that eliminate delays in diagnosis or treatment should be gamechangers for maternal health.”

The award-winning research programme is part of the University of Birmingham’s work to end preventable death and illness in mothers affected by postpartum haemorrhage, miscarriage and other pregnancy-related conditions around the globe.

The University is leading the way in women’s health research by championing the need to test safe and effect medicine use during pregnancy and breastfeeding, including jointly leading Europe’s largest miscarriage research centre – the Tommy’s National Centre for Miscarriage Research.

The breadth of research expertise extends to other women’s health priorities, including ovarian cancer, where research has been instrumental in changing National Institute of Clinical Excellence guidelines regarding surgical approach.

DaRe2THINK launches enhanced digital platform to transform clinical trials for GP practices

A new digital platform has been launched to transform how NHS GP practices take part in clinical trials, making research quicker, easier and more inclusive for patients across the UK.

The DaRe2THINK clinical trial, led by BHP founder-member the University of Birmingham and the Clinical Practice Research Datalink (CPRD; part of the Medicines and Healthcare products Regulatory Agency), and run in partnership with NHS providers and the NIHR Research Delivery Network, has developed the platform to reduce paperwork for GP staff and reach communities often underrepresented in research.

The platform securely links to existing GP systems, automatically transferring relevant health data to participating NHS General Practices, significantly reducing administrative burden on clinical staff. The enhanced functionality enables practice staff to rapidly identify suitable patient cohorts for NHS clinical trials and engage participants through integrated mobile messaging systems.

DaRe2THINK already securely screens routine healthcare records from over 13 million NHS patients across more than 450 General Practices in England. This builds upon efforts to embed research into everyday NHS care.

Puja Myles, Director of CPRD at the MHRA, said: “This platform represents a paradigm shift in how we conduct primary care research. By leveraging routine health data and advanced digital tools, we’re removing traditional barriers that have prevented many communities from accessing the benefits of clinical trial participation.”

The current DaRe2THINK trial is investigating whether earlier intervention with NHS treatments can prevent blood clots and memory loss in patients with atrial fibrillation, a common heart rhythm condition associated with vascular dementia. Notably, 25% of participating practices are in England’s most health-deprived areas, addressing long-standing inequalities in clinical research participation.

Dipak Kotecha, Professor of Cardiology at the University of Birmingham, said: “DaRe2THINK is leading the way to empower patients and provide an opportunity to take part in NHS clinical trials.

“The enhanced digital platform has now been rolled out across England, making it quicker and simpler for NHS staff to reach out to their patients, and embedding prevention into routine care.”

Dr Alexandra Lee, a General Practitioner at University of Birmingham, said: “The digital trial platform used in DaRe2THINK has had a positive impact on the delivery of primary care research and has helped recruit a new cohort of general practices that haven’t previously taken part in clinical trials.”

Charles Michaleis, a DaRe2THINK Participant, said: “The DaRe2THINK study was very easy to sign up to and get involved in, with the hope that this will lead to improved treatments for NHS patients who have atrial fibrillation.”

The trial is funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and supported by a dedicated public engagement team. The research was carried out at the NIHR Birmingham Biomedical Research Centre (BRC), a cross-BHP collaboration hosted by University Hospitals Birmingham.

DaRe2THINK aims to democratise access to clinical trials across all communities; the platform’s development aligns with the NHS People Plan to foster inclusive research culture and supports the broader goal of improving efficiency in community-based clinical trials.